Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancerD. Azria, J.P. Gérard, J. Doyen et al.|Annals of Oncology|2017Cited by 106
Proton Beam Therapy for Children With Neuroblastoma: Experiences From the Prospective KiProReg RegistryDanny Jazmati, Beate Timmermann, Sarina Butzer et al.|Frontiers in Oncology|2021Cited by 19
Fractionated Stereotactic Radiation Therapy for Pituitary Adenomas: An alternative escalating protocol of hypofractionated stereotactic radiotherapy delivering 35 Gy in 5 fractionsS. Sumodhee, Pierre‐Yves Bondiau, S. Hiéronimus et al.|Cancer/Radiothérapie|2021Cited by 3
Stereotactic Radiation Therapy for Pituitary Adenomas: Retrospective Analysis of an Alternative Multi-Fractionated Protocol with Robotic Radiosurgery Including 35 Gy in 5 FractionsV. Atallah, P.-Y. Bondiau, S. Sumodhee et al.|International Journal of Radiation Oncology*Biology*Physics|2019Cited by 0